Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for improving function of aortic endothelial cells and application thereof

A technology of endothelial cells and aorta, applied in the field of medicine, can solve the problems of high occult disease, high fatality and disability rate, achieve good application prospects, prevent the occurrence and progress of vascular diseases, and prevent the occurrence and development of the effect.

Active Publication Date: 2019-03-12
XI AN JIAOTONG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, atherosclerosis has drugs, surgery and other treatment methods, but this type of disease is highly occult, and has a high rate of death and disability, so early prevention is particularly important. Studies have reported that natural active ingredients such as chlorogenic acid, Paeoniae alba and lignans have anti-atherosclerosis functions, and functional foods based on them have come out one after another

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug for improving function of aortic endothelial cells and application thereof
  • Drug for improving function of aortic endothelial cells and application thereof
  • Drug for improving function of aortic endothelial cells and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] The present invention will be further described in detail below in conjunction with specific embodiments.

[0023] 1. Experimental materials

[0024] TRIzol reagent was purchased from Invitrogen; RNA reverse transcription kit and SYBR fluorescent dye were purchased from Dalian Bao Biological Company. RNA primer sequences were ordered and synthesized from Xi'an Qingke Jersey Biological Co., Ltd.

[0025] 2. Experimental cell culture and model establishment

[0026] Human aortic endothelial cells (Humanaortic endothelial cells, HAEC) were purchased from Shanghai Baili Biotechnology Co., Ltd., and palmitic acid was purchased from Sigma Company. Cells were cultured in 95% air and 5% CO 2 in a constant temperature, humidified, sterile incubator at 37°C. The experiment was divided into three groups, namely: (1) control group; (2) 500 μM palmitic acid treatment group; (3) drug protection group provided by the present invention.

[0027] 3. Experimental method

[0028] (1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of drugs and particularly relates to a drug for improving the function of aortic endothelial cells and application thereof. The drug has the beneficial effects that the inflammatory response of human aortic endothelial cells caused by saturated fatty acid can be obviously inhibited and the mitochondrial respiration and metabolism of vascular endothelialcells can be obviously enhanced; the occurrence and development of atherosclerosis can be prevented by resisting inflammation and protecting the mitochondrial function; the inflammatory response of human aortic endothelium caused by saturated fatty acid can be effectively reduced, such as mRNA level content of interleukin-6(IL-6) and matrix metalloproteinase-1(MMP-1); the saturated fatty acid canbe effectively prevented from damaging the mitochondrial function of the human aortic endothelial cells, such as increase of expression of mitochondrial complex I and III proteins and mitochondrial-metabolism-related Foxol protein and the like; the drug has good application prospect in preventing occurrence and progression of vascular diseases.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a medicine for improving the function of aortic endothelial cells and an application thereof. Background technique [0002] Data show that 17,700 people die of cardiovascular disease every year in the world, accounting for 31% of the death toll. The rate is significantly higher than other diseases, in a leading position. Cardiovascular diseases mainly include cardiovascular and cerebrovascular diseases, such as myocardial infarction and cerebral infarction. Atherosclerosis is the pathological basis of cardiovascular diseases. [0003] The pathogenesis of atherosclerosis is very complex. It occurs in the vessel wall and is a chronic inflammatory response, plaque formation, and vascular endothelial cell damage. Factors leading to atherosclerosis mainly include unhealthy diets such as high salt, high fat, high energy, and smoking, as well as metabolic risk factors, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/19A61K31/77A61K31/795A61P9/10A61P29/00
CPCA61K31/19A61K31/77A61K31/795A61P9/10A61P29/00A61K2300/00A61K47/34A61K47/44
Inventor 刘健康柳絮云张添洋叶志盛叶鼎一
Owner XI AN JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products